COVID-19 (Coronavirus)

Genetic Disorders of the Cardiovascular System Clinical Trials

As a patient at Cedars-Sinai, you will have access to the latest clinical trials and research for genetic disorders of the cardiovascular system. Backed by a respected team of specialists and researchers, our clinical trials aim to further the advancement of diagnosing and treating your condition.

Questions? See the Clinical Trials FAQs.

Condition: 

Hereditary heart disease

Key Inclusion Criteria:

  • Affected and unaffected family members from subjects with: Wolff-Parkinson-White syndrome, Brugada syndrome, idiopathic ventricular tachycardia and fibrillation, long QT syndrome, hypertrophic, dilated and restrictive cardiomyopathy, and supraventricular tachycardia

Summary:

This study focuses on individuals who have a hereditary form of heart disease, which may have occurred in isolated individuals or through inheritance, affecting multiple family members. The purpose of the study is to find the particular gene that causes the inherited form of heart disease. The study aims to obtain information on heart-related symptoms and genetic makeup, as well as those of family members who are either healthy or have heart disease.